SE447450B - Farmaceutiska kompositioner med ihallande frigoring i tabellform samt sett att framstella dessa - Google Patents

Farmaceutiska kompositioner med ihallande frigoring i tabellform samt sett att framstella dessa

Info

Publication number
SE447450B
SE447450B SE8100104A SE8100104A SE447450B SE 447450 B SE447450 B SE 447450B SE 8100104 A SE8100104 A SE 8100104A SE 8100104 A SE8100104 A SE 8100104A SE 447450 B SE447450 B SE 447450B
Authority
SE
Sweden
Prior art keywords
tablet
starch
amount
pharmaceutical composition
cellulose
Prior art date
Application number
SE8100104A
Other languages
English (en)
Swedish (sv)
Other versions
SE8100104L (sv
Inventor
J M Dunn
J F Lampard
Original Assignee
Boots Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/194,453 external-priority patent/US4308251A/en
Application filed by Boots Co Ltd filed Critical Boots Co Ltd
Publication of SE8100104L publication Critical patent/SE8100104L/
Publication of SE447450B publication Critical patent/SE447450B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8100104A 1980-01-11 1981-01-09 Farmaceutiska kompositioner med ihallande frigoring i tabellform samt sett att framstella dessa SE447450B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11143080A 1980-01-11 1980-01-11
US06/194,453 US4308251A (en) 1980-01-11 1980-10-17 Controlled release formulations of orally-active medicaments

Publications (2)

Publication Number Publication Date
SE8100104L SE8100104L (sv) 1981-07-12
SE447450B true SE447450B (sv) 1986-11-17

Family

ID=26808896

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8100104A SE447450B (sv) 1980-01-11 1981-01-09 Farmaceutiska kompositioner med ihallande frigoring i tabellform samt sett att framstella dessa

Country Status (22)

Country Link
JP (1) JPS56103110A (it)
AT (1) AT374681B (it)
AU (1) AU542824B2 (it)
BE (1) BE886998A (it)
CA (1) CA1140466A (it)
CH (1) CH646604A5 (it)
DE (1) DE3100191A1 (it)
DK (1) DK6181A (it)
ES (2) ES498369A0 (it)
FI (1) FI76927C (it)
FR (1) FR2473308B1 (it)
GB (1) GB2067072B (it)
GR (1) GR73843B (it)
IE (1) IE50806B1 (it)
IN (1) IN151913B (it)
IT (1) IT1221041B (it)
LU (1) LU83052A1 (it)
NL (1) NL8100037A (it)
NO (1) NO156153C (it)
NZ (1) NZ195933A (it)
SE (1) SE447450B (it)
ZA (1) ZA81136B (it)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2496082A (en) * 1947-05-24 1950-01-31 Ashenfelter William Scaffold structure
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
JPS59227817A (ja) * 1983-06-07 1984-12-21 Toyo Jozo Co Ltd 持続性経口用ブレデニン製剤
JPH0662404B2 (ja) * 1983-06-14 1994-08-17 シンテックス・ファーマシユーテイカルズ・インターナシヨナル・リミテツド 制御放出性ナプロキセンおよびナプロキセンナトリウム錠
ZA836030B (en) * 1983-08-16 1985-02-27 Verex Lab Constant order release solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
ZA836031B (en) * 1983-08-16 1985-02-27 Verex Lab Constant release rate solid dosage theophylline formulation
EP0138216B1 (en) * 1983-10-14 1993-01-07 Sumitomo Pharmaceuticals Company, Limited Sustained-release ifn preparation for parenteral administration
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
US4855134A (en) * 1983-10-14 1989-08-08 Sumitomo Pharmaceuticals Company, Limited Sustained-release preparation
EP0230647B1 (en) * 1985-12-27 1993-03-31 Sumitomo Pharmaceuticals Company, Limited Method for producing a sustained release formulation
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
CA1316110C (en) * 1987-02-27 1993-04-13 Peter Lloyd Oren Sustained release matrix formulations
US4968508A (en) * 1987-02-27 1990-11-06 Eli Lilly And Company Sustained release matrix
US5855915A (en) * 1995-06-30 1999-01-05 Baylor University Tablets or biologically acceptable implants for long-term antiinflammatory drug release

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2953497A (en) * 1953-06-03 1960-09-20 Howard A Press Therapeutic tablets
NL265428A (it) * 1960-06-06
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
GB1500300A (en) * 1975-01-06 1978-02-08 Ciba Geigy Ag Pharmaceutical preparation for the treatment of circulatory disorders
JPS5411226A (en) * 1977-06-24 1979-01-27 Shin Etsu Chem Co Ltd Disintegratable granule

Also Published As

Publication number Publication date
NO156153B (no) 1987-04-27
FI76927C (fi) 1989-01-10
AU542824B2 (en) 1985-03-14
NO810062L (no) 1981-07-13
SE8100104L (sv) 1981-07-12
ATA5481A (de) 1983-10-15
NZ195933A (en) 1982-11-23
FR2473308A1 (fr) 1981-07-17
DK6181A (da) 1981-07-12
FI810056L (fi) 1981-07-12
AT374681B (de) 1984-05-25
ES509179A0 (es) 1982-12-16
AU6597681A (en) 1981-07-16
ES8205353A1 (es) 1982-06-01
IN151913B (it) 1983-09-03
DE3100191A1 (de) 1981-12-10
NL8100037A (nl) 1981-08-03
FR2473308B1 (fr) 1985-07-19
BE886998A (fr) 1981-07-08
FI76927B (fi) 1988-09-30
IE50806B1 (en) 1986-07-23
ES498369A0 (es) 1982-06-01
NO156153C (no) 1987-08-05
GB2067072A (en) 1981-07-22
IT8147537A0 (it) 1981-01-09
LU83052A1 (fr) 1982-09-10
ES8301629A1 (es) 1982-12-16
GB2067072B (en) 1983-08-10
IE810036L (en) 1981-07-11
DE3100191C2 (it) 1988-09-01
ZA81136B (en) 1982-01-27
GR73843B (it) 1984-05-07
IT1221041B (it) 1990-06-21
JPS56103110A (en) 1981-08-18
CA1140466A (en) 1983-02-01
CH646604A5 (fr) 1984-12-14

Similar Documents

Publication Publication Date Title
SE447450B (sv) Farmaceutiska kompositioner med ihallande frigoring i tabellform samt sett att framstella dessa
AU662239B2 (en) Controlled release morphine preparation
US3965256A (en) Slow release pharmaceutical compositions
US3632739A (en) Solid sustained release pharmaceutical preparation
JPH08500110A (ja) ブプロピオン含有持続放出型錠剤
KR930008956B1 (ko) 서방형 이부프로펜 제제의 제조방법
JPS6327439A (ja) 持続性薬効製剤
JPH03500288A (ja) 徐放性ニフェジピン製剤
JP2849047B2 (ja) ジクロフェナクナトリウム持続性製剤およびその製法
AU2002213900A1 (en) Pharmaceutical compositions
WO2002020090A2 (en) Pharmaceutical compositions
JP2007055924A (ja) イブプロフェン及び塩酸アンブロキソール含有固形製剤
EP0025686B1 (en) Pharmaceutical composition containing paracetamol, treatment pack comprising said composition and method of reducing liver toxicity effect of paracetamol compositions
JPH029007B2 (it)
Rahul et al. A review on immediate release drug delivery systems
JPH0920663A (ja) イブジラストを含有する徐放性細粒剤およびその製法
US4652442A (en) Process of producing a sustained release preparation containing indomethacin or niomethacin
Brkich et al. Scientific and Methodical approach to developing the formulation of an Innovative Medicinal Product based on a derivative of 3, 7-diazabicyclo [3.3. 1] nonane (hydrindane)
WO2015011162A1 (en) Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation
JP2003221326A (ja) 分岐鎖アミノ酸を含有するチュアブル剤
JPH05194233A (ja) マイクロペレットおよびそれらの製造方法
JP4064493B2 (ja) ビタミン類含有組成物
JP3202775B2 (ja) 固形製剤
CN105407875A (zh) 包含异烟肼颗粒和利福喷汀颗粒的呈包衣片剂形式的抗结核病的稳定的药物组合物及其制备方法
JPH11322584A (ja) ベザフィブラート徐放性製剤

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8100104-2

Effective date: 19901211

Format of ref document f/p: F